MISSION/HISTORY
  DIRECTOR
  Sylvain Bourgoin     
 
  RESEARCHERS
  Fawzi Aoudjit          
  Pierre Borgeat        
  Maria Fernandes     
  Louis Flamand         
  François Marceau          
  Paul Naccache     
  Patrice Poubelle      
  Marc Pouliot            
  Patrick Provost        
  Raynald Roy            
  Jean Sévigny           
 
  SCIENTIFIC MEETINGS
  PERSONNEL/BUDGET
  VIRTUAL VISIT
  ALUMNI
Any questions?

Webmaster

Louis FLAMAND, PhD MBA
Professor, Department of Anatomy and Physiology, Faculty of Medicine, Université Laval.


Centre de Recherche en
Rhumatologie et Immunologie
2705, Boulevard Laurier, local T1-49
Quebec, QC
G1V 4G2 Canada
Tel: 418-656-4141 ext. 46164 (office)
Tel: 418-656-4141 ext. 46101 (laboratory)
Fax: 418-654-2765
E-mail:
Louis.Flamand@crchul.ulaval.ca

Research Themes | Research Projects | Selected References | List of Publications | Research Personnel | Additional Information

Research Themes

Molecular biology and pathogenesis of Human Herpes virus 8
Molecular biology and pathogenesis of Human Herpes virus 6

Top of page

Research Projects
>> MOLECULAR BIOLOGY AND PATHOGENESIS OF HUMAN HERPES VIRUS 8  
 

Kaposi's sarcoma (KS) is an angioproliferative disease observed in elderly men of Mediterranean origin (classical KS), in Africa (endemic KS) and in individuals infected with the human immunodeficiency virus (HIV) (AIDS-KS). The risk factor for developing KS is several times greater if seropositive for HIV-1, suggesting that HIV-1 infection, directly or indirectly, contributes to KS development. In addition, classical and endemic KS are rather mild compared to the AIDS-KS, which is very aggressive. Recent epidemiological data have linked the human herpes virus 8 (HHV-8) to all forms of KS with more than 95% of all KS lesions examined were positive for HHV-8 DNA sequences. Moreover, the detection of HHV-8 DNA in the peripheral blood mononuclear cells (PBMC) of AIDS patients appears predictive of KS development. These data strongly support a role for HHV-8 in the development of KS. My laboratory is currently studying the biology of v-Flip, v-Cyclin and LANA-1, three latency-associated proteins of HHV-8 in order to understand how these can contribute to pathogenesis. Furthermore, with the use of specific mutants, our goal is to identify HHV-8 genes that are essential for viral transformation/immortalization of primary endothelial cells. Lastly, the role of HIV-1 and HIV-1 associated proteins in HHV-8 infection and immortalization process is investigated.

These projects are supported by grants from the
Canadian Institutes of Health Research (CIHR) and the
National Cancer Institute of Canada.

Top of page

 
>> MOLECULAR BIOLOGY AND PATHOGENESIS OF HUMAN HERPES VIRUS 6
Herpes viruses are complex pathogens and like all viruses, they strictly depend on host cells to propagate themselves. As with most DNA viruses, many events of the Herpes virus life cycle take place in the nucleus of the infected cell. The Immediate-Early (IE) proteins, translated into the cytoplasm, must travel back to the nucleus, interact with the nuclear pore complex and reach the nucleoplasm to continue the infectious process. Considering that the IE proteins are the first to be synthesized within the infected cells and that they play a crucial role in the success of the infectious process, the Herpes virus IE proteins are actively studied. For the past several years our laboratory has focused on the use of human Herpes virus 6 (HHV-6) as a model for -Herpes virus infection. Lately, our research efforts were devoted to an understanding of the functions of IE proteins and we recently reported on the cloning and the initial characterization of HHV-6 two major IE proteins, IE1 and IE2. Over the next few years we propose to extend our knowledge of the IE proteins and dissect their close association with the nuclear import and the transcriptional machineries.

This project is supported by
the Canadian Institutes of Health Research (CIHR).

Top of page

Selected references  
 

Gravel, A., Gosselin, J., and Flamand L. 2002. Human Herpesvirus 6 immediate-early 1 protein is a sumoylated nuclear phophoprotein co-localizing with promyelocytic leukemia protein-associated nuclear bodies. J. Biol.Chemistry. 277: 19679-19687. PubMed Link

Cloutier, N., Grandvaux, N., and Flamand, L. 2007. Synergistic activation of interferon-beta gene transcription by the viral FLICE inhibitory protein of Kaposi's sarcoma-associated herpesvirus and type I IFN activators. Eur. J. Immunol. 37:2772-2778. PubMed Link

Flamand, L., Tremblay, M.J., and Borgeat, P. 2007. Leukotriene B4 triggers the in vitro and in vivo release of potent antimicrobial agents. J. Immunol. 178:8036-8045. PubMed Link

Jaworska, J., Gravel, A., Fink, K., Grandvaux, N., and Flamand, L. 2007. Inhibition of transcription of the beta interferon gene by the human herpesvirus 6 immediate-early 1 protein. J. Virol. 81:5737-5748. PubMed Link

Lefort, S., Soucy-Faulkner, A., Grandvaux, N., and Flamand, L. 2007. Binding of Kaposi's sarcoma-associated herpesvirus K-bZIP to interferon-responsive factor 3 elements modulates antiviral gene expression. J. Virol. 81:10950-10960. PubMed Link

Top of page

 

List of Publications - PubMed Link

Top of page

Research Personnel      
  Research Associates   Graduate Students
 

Annie Gravel, PhD
Nancy Verville, DEC

 

Joanna Jaworska MSc
Marie-Ève Janelle, MSc
Nathalie Cloutier, MSc
Sylvain Lefort DESS

Additional Information Details